CAL
PBH icon

Capital Advisors Ltd’s Prestige Consumer Healthcare PBH Stock Holding History

Capital Advisors Ltd’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Sell
2
-18
-90% -$925 ﹤0.01% 1528
2026
Q1 		$1K Hold
20
– – ﹤0.01% 1272
2025
Q4 		$1K Sell
20
-11
-35% -$673 ﹤0.01% 1252
2025
Q3 		$2K Sell
31
-76
-71% -$5.29K ﹤0.01% 1084
2025
Q2 		$9K Hold
107
– – ﹤0.01% 822
2025
Q1 		$9K Hold
107
– – ﹤0.01% 808
2024
Q4 		$8K Hold
107
– – ﹤0.01% 836
2024
Q3 		$8K Hold
107
– – ﹤0.01% 824
2024
Q2 		$7K Buy
107
+87
+435% +$5.89K ﹤0.01% 840
2024
Q1 		$1K Hold
20
– – ﹤0.01% 1243
2023
Q4 		$1K Hold
20
– – ﹤0.01% 1193
2023
Q3 		$1K Hold
20
– – ﹤0.01% 1186
2023
Q2 		$1K Sell
20
-14
-41% -$838 ﹤0.01% 1195
2023
Q1 		$2K Buy
34
+7
+26% +$437 ﹤0.01% 920
2022
Q4 		$2K Hold
27
– – ﹤0.01% 886
2022
Q3 		$1K Buy
+27
New +$1.5K ﹤0.01% 1087

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Advisors Ltd's PBH Position: Q2 2026 in Review

Capital Advisors Ltd reduced its Prestige Consumer Healthcare (PBH) stake by 90% in Q2 2026, selling an estimated $925 and leaving 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

Capital Advisors Ltd first reported a position in PBH in Q3 2022 and has held it in 16 quarters since. The position peaked at $9K in Q2 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Capital Advisors Ltd held 2 shares of Prestige Consumer Healthcare worth $0 as of Q2 2026.
  • Capital Advisors Ltd sold 18 Prestige Consumer Healthcare shares in Q2 2026, an estimated $925.
  • Prestige Consumer Healthcare made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1528 holding.
  • Capital Advisors Ltd first reported a position in Prestige Consumer Healthcare in Q3 2022 and has held it in 16 quarters since.
  • Capital Advisors Ltd's Prestige Consumer Healthcare position peaked at $9K in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.